SHANGHAI, China, Aug. 7 /Xinhua-PRNewswire-FirstCall/ -- Aamaxan Transport Group, Inc. (the "Company" or "ATG") (OTC Bulletin Board: AAXT), through its subsidiaries, including Shanghai Medical Technology Co., Ltd. ("Shanghai Medical"), a PRC company and a leading provider of Hemodialysis equipment ("HDE") and other related supplies and services, including disposable and diagnostic products, throughout Eastern China, today announced the appointment of Mr. Xu Yifei as the company's chief financial officer effective August 1, 2008.
For the last six years Mr. Xu has served as Vice President and Chief Operating Officer of Shanghai Medical. Mr. Xu obtained two degrees, including a major in both finance and internal controls, which were earned from Shanghai University of Finance and Economics, and from Shanghai Commerce accounting college in Shanghai PRC, respectively.
Mr. Xu assumed the position as the Company's CFO on August 1, 2008 and will report directly to Mr. Chen Zhong, CEO of Shanghai Medical. Mr. Xu will be responsible for all financial reporting activities, in addition to managing the Company's overall financial planning and control activities.
"Mr. Xu will be an integral part of our management team, especially as we seek to increase transparency, raise our corporate governance standards and gain more exposure in the US investment community," commented Mr. Chen. "I am eager to continue working with Mr. Chen in my new role as CFO to accomplish Shanghai Medical's goals as a US listed public company," stated Mr. Xu.
About Shanghai Medical Technology Co., Ltd.
Shanghai Medical is a leading provider of Hemodialysis and renal care
equipment, supplies, and related support services in Eastern China.
Specifically, Shanghai Medical distributes and sells Hemodialysis equipment
("HDE") which is mainly used by hospitals and medical facilities and
includes machines, dialyzers, disposables and diagnostic products used in
|SOURCE Aamaxan Transport Group, Inc.|
Copyright©2008 PR Newswire.
All rights reserved